BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 18338380)

  • 1. Evidence for communality in the primary determinants of CYP74 catalysis and of structural similarities between CYP74 and classical mammalian P450 enzymes.
    Hughes RK; Yousafzai FK; Ashton R; Chechetkin IR; Fairhurst SA; Hamberg M; Casey R
    Proteins; 2008 Sep; 72(4):1199-211. PubMed ID: 18338380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Medicago truncatula (barrel medic) hydroperoxide lyase (CYP74C3), a water-soluble detergent-free cytochrome P450 monomer whose biological activity is defined by monomer-micelle association.
    Hughes RK; Belfield EJ; Muthusamay M; Khan A; Rowe A; Harding SE; Fairhurst SA; Bornemann S; Ashton R; Thorneley RN; Casey R
    Biochem J; 2006 May; 395(3):641-52. PubMed ID: 16454766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP74C3 and CYP74A1, plant cytochrome P450 enzymes whose activity is regulated by detergent micelle association, and proposed new rules for the classification of CYP74 enzymes.
    Hughes RK; Belfield EJ; Casey R
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1223-7. PubMed ID: 17073790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants governing the CYP74 catalysis: conversion of allene oxide synthase into hydroperoxide lyase by site-directed mutagenesis.
    Toporkova YY; Gogolev YV; Mukhtarova LS; Grechkin AN
    FEBS Lett; 2008 Oct; 582(23-24):3423-8. PubMed ID: 18789329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biogenesis of volatile aldehydes from fatty acid hydroperoxides: molecular cloning of a hydroperoxide lyase (CYP74C) with specificity for both the 9- and 13-hydroperoxides of linoleic and linolenic acids.
    Tijet N; Schneider C; Muller BL; Brash AR
    Arch Biochem Biophys; 2001 Feb; 386(2):281-9. PubMed ID: 11368353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double function hydroperoxide lyases/epoxyalcohol synthases (CYP74C) of higher plants: identification and conversion into allene oxide synthases by site-directed mutagenesis.
    Toporkova YY; Gorina SS; Bessolitsyna EK; Smirnova EO; Fatykhova VS; Brühlmann F; Ilyina TM; Mukhtarova LS; Grechkin AN
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Apr; 1863(4):369-378. PubMed ID: 29325723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationship in the CYP74 family: conversion of divinyl ether synthases into allene oxide synthases by site-directed mutagenesis.
    Toporkova YY; Ermilova VS; Gorina SS; Mukhtarova LS; Osipova EV; Gogolev YV; Grechkin AN
    FEBS Lett; 2013 Aug; 587(16):2552-8. PubMed ID: 23827817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding.
    Kim D; Guengerich FP
    Arch Biochem Biophys; 2004 Dec; 432(1):102-8. PubMed ID: 15519301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-directed mutagenesis of the putative distal helix of peroxygenase cytochrome P450.
    Matsunaga I; Ueda A; Sumimoto T; Ichihara K; Ayata M; Ogura H
    Arch Biochem Biophys; 2001 Oct; 394(1):45-53. PubMed ID: 11566026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of amino acid residues critical for unique activities of rabbit cytochrome P450 2B5 using hybrid enzymes and reciprocal site-directed mutagenesis with rabbit cytochrome P450 2B4.
    Szklarz GD; He YQ; Kedzie KM; Halpert JR; Burnett VL
    Arch Biochem Biophys; 1996 Mar; 327(2):308-18. PubMed ID: 8619620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular model of human CYP21 based on mammalian CYP2C5: structural features correlate with clinical severity of mutations causing congenital adrenal hyperplasia.
    Robins T; Carlsson J; Sunnerhagen M; Wedell A; Persson B
    Mol Endocrinol; 2006 Nov; 20(11):2946-64. PubMed ID: 16788163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
    Narasimhulu S
    Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking of Glycine max and Medicago truncatula ureases with urea; bioinformatics approaches.
    Filiz E; Vatansever R; Ozyigit II
    Mol Biol Rep; 2016 Mar; 43(3):129-40. PubMed ID: 26852122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of human cytochrome P450 1A2 mutants with enhanced catalytic activity for heterocyclic amine N-hydroxylation.
    Kim D; Guengerich FP
    Biochemistry; 2004 Feb; 43(4):981-8. PubMed ID: 14744142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-directed mutagenesis of putative substrate recognition sites in cytochrome P450 2B11: importance of amino acid residues 114, 290, and 363 for substrate specificity.
    Hasler JA; Harlow GR; Szklarz GD; John GH; Kedzie KM; Burnett VL; He YA; Kaminsky LS; Halpert JR
    Mol Pharmacol; 1994 Aug; 46(2):338-45. PubMed ID: 8078495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green leaf divinyl ether synthase: gene detection, molecular cloning and identification of a unique CYP74B subfamily member.
    Gogolev YV; Gorina SS; Gogoleva NE; Toporkova YY; Chechetkin IR; Grechkin AN
    Biochim Biophys Acta; 2012 Feb; 1821(2):287-94. PubMed ID: 22155387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.
    Lewis DF
    J Inorg Biochem; 2002 Sep; 91(4):502-14. PubMed ID: 12237218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An inhibitory monoclonal antibody binds in close proximity to a determinant for substrate binding in cytochrome P450IIC5.
    Kronbach T; Johnson EF
    J Biol Chem; 1991 Apr; 266(10):6215-20. PubMed ID: 1706711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modelling of CYP2A6 based on the CYP2C5 crystallographic template: enzyme-substrate interactions and QSARs for binding affinity and inhibition.
    Lewis DF; Lake BG; Dickins M; Goldfarb PS
    Toxicol In Vitro; 2003 Apr; 17(2):179-90. PubMed ID: 12650672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.